Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05914064 · ClinicalTrials.gov registry record · NA
Gravitas Feeding Tube System Placement Validation in Neonates
A NA study of Nasogastric Tube, sponsored by Gravitas Medical.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 5
- Study locations
NCT05914064 is a NA study of Nasogastric Tube that is active but no longer recruiting, run by Gravitas Medical. The registered enrollment target is 100 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT05914064, a NA study of Nasogastric Tube, is active but no longer recruiting, sponsored by Gravitas Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to validate the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.
Conditions Studied
Interventions
- DEVICE Gravitas FT and Gravitas FT Monitor guidance
Study Locations (5)
California
- Lucile Packard (Stanford) Children's Hospital - Stanford
Georgia
- Memorial Health University Medical Center - Savannah
Massachusetts
- Boston Children's Hospital - Boston
Rhode Island
- Women & Infants Hospital, Rhode Island - Providence
Virginia
- University of Virginia Children's Health - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-10-27 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05914064
The ClinicalTrials.gov registry entry for NCT05914064 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gravitas Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nasogastric Tube appearing as the primary indexed condition, and to 1 intervention - of which Gravitas FT and Gravitas FT Monitor guidance is the first listed.
NCT05914064 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Georgia, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05914064 about?
NCT05914064 is a clinical study titled "Gravitas Feeding Tube System Placement Validation in Neonates". The purpose of this study is to validate the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.
What is the current status of trial NCT05914064?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-10-27. Estimated completion is 2026-12.
What conditions does trial NCT05914064 study?
This clinical trial studies the following conditions: Nasogastric Tube.
What interventions are being tested in trial NCT05914064?
The interventions under investigation include: Gravitas FT and Gravitas FT Monitor guidance (DEVICE).
Who is sponsoring clinical trial NCT05914064?
This trial is sponsored by Gravitas Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05914064 being conducted?
This trial has 5 study locations across California, Georgia, Massachusetts, Rhode Island, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.